We focus on Essential Drugs.
- Critical Care
- Emergency Care
- Rare Diseases
- Metabolic Disorders
SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.
Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.
Our commitment is to continue to offer essential drugs meeting Public Health needs.
Our therapeutic areas
SERB benefits from a portfolio of specialty products in
Critical Care and Rare Diseases
SERB has recently strengthened its Neurology and Rare Diseases franchise
with the acquisition of Veriton pharma
SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines (for more information)
SERB has consolidated a global leading position in
Emergency Care: wide range of lifesaving medical countermeasures and intensive care medicines
Surgery: drugs and devices for supportive care as well as diagnostic agents
SERB has extended its portfolio into the treatment of
Neurology: treatments for rare and severe epileptic and neuromuscular conditions
Metabolic disorders: medicines for paediatric inborn errors of metabolism
An international presence
SERB Specialty Pharmaceuticals is global pharmaceutical group with a direct presence in Europe, in the Middle East and Australia, and over 80 countries including the US and Japan through a broad network of experienced distributors.
Avenue Louise 480
8 rue Beaumont
Eagle Court, 9 Vine Street, Uxbridge
Middlesex, UB8 1 QE
Veriton Pharma Ltd
Unit 16, Trade City,
Avro Way, Weybridge
Surrey, KT13 0YF
40 Avenue George V
SERB SP. ZO.O.
Pl. Pilsudkiego 1,
United Arab Emirates
Veriton MEA FZCo
Building 3W, Office 210
DAFZA PO Box 293727